Noom

🎉Meet us in St. Pete Beach! Noom will be attending the Health Benefits Conference & Expo this year  –  stop by Booth 206 with Michael Sweetser to hear how Noom can help you offer effective health and wellness benefits for your organization. Get the tools you need to demonstrate the value of your health and wellness benefits, lower costs, and much more at HBCE. See you there!

The nationwide GLP-1 shortage has been a key topic in healthcare since late 2022. Compounding provided a temporary solution for Americans unable to access or afford branded GLP-1s, but the future of these alternatives is now uncertain. As the production of branded GLP-1s ramps up, questions loom about the ability of all Americans to continue to have fair and equitable access to these life-changing medications. Check out our latest blog for insights into the evolving GLP-1 landscape and what the end of the shortage really means. 👉 https://lnkd.in/dvWTRhN6 #GLP1 #HealthcareInsights #AffordableCare #HealthEquity #Wellness

📣 Noom just launched 2 FREE features to help you track progress, understand your body, and stay motivated: 1. AI Body Scan – In just 10 seconds, use your smartphone camera to generate a personalized 3D model of your body, helping you track changes over time. 2. Noom Body Age Prediction – Get an estimate of your biological body age based on key health factors and see what small changes can help you feel healthier. Wellness should be accessible to everyone! 💪 Learn more: https://lnkd.in/gQue-XqC

🚨ATTN: Noom is going to the NEEBC for Innovation in Employee Benefits: Changing the Game this year! Join Noom’s Michael Sweetser and Jackie Johnson, CEBS, as we learn all things employee benefits and total rewards for professionals in New England and beyond. Come advance your knowledge and network with fellow employee benefits and rewards practitioners, consultants, and providers of services with Noom!

🩺 How is Noom shaping the future of digital healthcare? Noom's GLP-1 Companion just got a major upgrade in Preparation for the Newly Expected Prescription Drug Use-Related Software (PDURS) Model, including new features like our AI-driven Welli Meal Planner and Dynamic Calorie Goals, all designed to enhance wellness outcomes. Read more about it:

Glad to see POLITICO's coverage of Noom's newest GLP-1 Companion update.. "The weight-loss platform Noom is rolling out a software update Monday that it says could be a model for the FDA to consider as drug companies look to software add-ons to their labels to encourage medication adherence for GLP-1s. "We believe that there's going to be kind of a gold rush toward these digital solutions - not just in GLP-1s ..." Cook told POLITICO ahead of the announcement. "The fundamental thing here is Pharma companies are going to be looking for different ways to distinguish themselves in a crowded market." Why it matters: The draft framework essentially allows a firm to conduct cheaper Phase IV studies of a software companion when a drug is already on the market, rather than randomly controlled Phase III trials in which the medicine and app are evaluated together. If the guidance is finalized, it will give companies like Noom the opportunity to be the platform of choice for drug-software combination products, Cook said, even beyond weight-loss drugs. "We're positioning for a future where every GLP-1 - every pharmaceutical company with a GLP-1 - is going to have a PDURS solution paired with it," he said."

💭 GLP-1s are among the most promising medications of our lifetime - but only if they make it to the people who need them. Read our co-Founder and Executive Chairman Saeju Jeong on why building trust in the healthcare ecosystem is essential to tapping into GLP-1's maximum potential.

From family planning and postnatal care to menopause and healthy aging, women in the workforce face unique health challenges across every stage of life. Employers have an opportunity to make a meaningful impact by offering comprehensive health benefits that include access to: ✅ Mental health resources  ✅ Stress management tools and healthy lifestyle guidance  ✅ Weight management programs  By supporting the diverse needs of women, organizations can foster a healthier, happier workforce. Want to learn actionable strategies to improve employee wellbeing? Check out our guide on supporting women’s health at work. https://lnkd.in/epyfQrAY #WomensHealth #EmployeeWellness #HRInsights

GLP-1 medications have reshaped the future of obesity care, but research shows medication alone is not enough for lasting results. The challenge: ~ 50% of weight lost while on a GLP-1 is regained within the first year after stopping the medication. Why? Without the right support, patients can’t make the lasting changes needed to see long-term results. They’re vulnerable not only to weight gain, but to more serious health risks that lead to increased healthcare costs. Noom’s GLP-1 Companion Program is designed to close the care gap and support patients in developing sustainable healthy habits alongside their medication. Learn how we’re helping create lasting health change. 👉 Check out our guide: Mind the GLP-1 Care Gap. https://lnkd.in/e_wzG_W2 #HealthCareInnovation #ObesityCare #HealthyLiving

GLP-1 medications are a game-changer in the treatment of obesity - a challenge impacting millions of U.S. workers. Yet, the high cost is a significant concern for companies looking to balance access with affordability. Watch our on-demand webinar to learn how Noom is breaking the GLP-1 cost cycle and helping organizations provide affordable access to GLP-1s and other anti-obesity medications regardless of their coverage policies. Get insights on: ✔️ How the obesity crisis is affecting employers ✔️ The impact of GLP-1 compounds  ✔️ How Noom can help you confidently manage GLP-1 costs and achieve long-term ROI 📺 Watch the webinar now  https://lnkd.in/eBkEKWeC #EmployeeWellness #GLP1 #HealthBenefits #HRInsights